FİNANSAL RAPORLAMA KALİTESİNİN TEORİK ÇERÇEVEDE ANALİZİ: AZERBAYCAN BORSASINDAN SEÇİLMİŞ ŞİRKETLER ÜZERİNE DEĞERLENDİRME
Tikintinin iqtisadiyyatı və menecment · 2025-05 · 2 · 348-355
DOI: 10.58225/tim.2026-2-348-355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tikintinin iqtisadiyyatı və menecment, 2025-05. Verfasst von N.İ. İsmayılov.
Abstract (Originalsprache)
Financial reporting quality represents a critical component of well-functioning capital markets, as it directly influences investors’ ability to make rational decisions and supports the efficient allocation of economic resources. Financial statements serve as a primary communication tool between companies and stakeholders, providing structured information about financial position, performance, and cash flows. The credibility, transparency, and reliability of this information significantly shape market confidence and overall economic stability. In emerging economies, insufficient reporting quality often intensifies information asymmetry, weakens investor trust, and limits the development of capital markets. For this reason, a comprehensive examination of financial reporting quality from both conceptual and empirical perspectives is essential. This study aims to analyze financial reporting quality within a structured theoretical framework and to evaluate selected companies listed on the Azerbaijan Stock Exchange. The concept of reporting quality is assessed through multiple dimensions, including earnings sustainability, the soundness of accounting estimates, adequacy of disclosures, consistency of reporting practices, and timeliness of financial information. The theoretical foundation of the study draws upon agency theory, information asymmetry theory, and stakeholder theory to explain managerial reporting behavior and the economic consequences of disclosure decisions. The empirical analysis focuses on reviewing the financial statements and accompanying notes of selected listed firms. The level of compliance with International Financial Reporting Standards (IFRS), transparency of reporting practices, and depth of information disclosure are systematically examined. In addition, the study evaluates the role of corporate governance structures, the effectiveness of independent audit mechanisms, and the strength of internal control systems in shaping reporting quality. The relationship between reporting quality and capital market performance is also considered within the broader institutional context. The findings reveal noticeable variations in reporting quality among the examined companies. Firms characterized by stronger governance frameworks, effective oversight mechanisms, and a greater commitment to transparent disclosure tend to demonstrate higher-quality financial reporting. Conversely, companies with limited disclosure practices and weaker monitoring structures show comparatively lower reporting quality, which may negatively influence investor perception. Overall, the study highlights the strategic importance of enhancing financial reporting quality in Azerbaijan’s capital market. Strengthening regulatory oversight, improving adherence to reporting standards, and promoting robust governance practices are identified as key steps toward increasing investor confidence and supporting long-term market sustainability.
Zitieren
APA
İsmayılov, N. (2025). FİNANSAL RAPORLAMA KALİTESİNİN TEORİK ÇERÇEVEDE ANALİZİ: AZERBAYCAN BORSASINDAN SEÇİLMİŞ ŞİRKETLER ÜZERİNE DEĞERLENDİRME. Tikintinin iqtisadiyyatı və menecment, 2, 348-355. https://doi.org/10.58225/tim.2026-2-348-355
Vancouver
İsmayılov N. FİNANSAL RAPORLAMA KALİTESİNİN TEORİK ÇERÇEVEDE ANALİZİ: AZERBAYCAN BORSASINDAN SEÇİLMİŞ ŞİRKETLER ÜZERİNE DEĞERLENDİRME. Tikintinin iqtisadiyyatı və menecment. 2025;2:348-355. doi:10.58225/tim.2026-2-348-355
BibTeX
@article{smaylov2025,
author = {İsmayılov, N.İ.},
title = {FİNANSAL RAPORLAMA KALİTESİNİN TEORİK ÇERÇEVEDE ANALİZİ: AZERBAYCAN BORSASINDAN SEÇİLMİŞ ŞİRKETLER ÜZERİNE DEĞERLENDİRME},
journal = {Tikintinin iqtisadiyyatı və menecment},
year = {2025},
volume = {2},
pages = {348--355},
doi = {10.58225/tim.2026-2-348-355}
}
EUVIMED